Allianz Asset Management GmbH - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$808,000
-33.1%
179,225
+9.3%
0.00%0.0%
Q1 2022$1,208,000
-0.4%
163,985
-12.4%
0.00%0.0%
Q4 2021$1,213,000
+56.7%
187,101
+40.7%
0.00%0.0%
Q3 2021$774,000
-36.4%
132,948
+12.7%
0.00%0.0%
Q2 2021$1,217,000
-34.2%
117,934
-32.9%
0.00%
-50.0%
Q1 2021$1,849,000
-61.1%
175,789
-42.8%
0.00%
-60.0%
Q4 2020$4,754,000
+67.2%
307,103
+57.6%
0.01%
+66.7%
Q3 2020$2,844,000
-24.8%
194,817
-2.4%
0.00%
-25.0%
Q2 2020$3,780,000
+106.3%
199,547
+109.2%
0.00%
+100.0%
Q1 2020$1,832,000
+18.1%
95,372
+17.8%
0.00%
+100.0%
Q4 2019$1,551,000
+50.0%
80,955
-26.7%
0.00%0.0%
Q4 2018$1,034,000
-44.1%
110,398
+1.7%
0.00%
-50.0%
Q3 2018$1,850,000
+10.2%
108,603
+9.9%
0.00%0.0%
Q2 2018$1,679,000
-37.4%
98,818
+0.2%
0.00%
-33.3%
Q2 2015$2,684,000
-44.4%
98,640
-37.4%
0.00%
-50.0%
Q1 2015$4,827,000157,6830.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders